Wells Fargo raised the firm’s price target on Universal Health to $255 from $200 and keeps an Overweight rating on the shares. The firm notes Hospital results and guides in Q2 generally exceeded expectations. Wells cites higher estimates and rolling forward for the price target raise. The firm expects the second half of 2024 fundamentals to remain fairly strong but 2025/2026 seems likely to be more normalized.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health upgraded to Overweight from Equal Weight at Barclays (Friday)
- Universal Health price target raised to $220 from $183 at TD Cowen
- Universal Health upgraded to Neutral from Underweight at Cantor Fitzgerald
- Universal Health upgraded to Overweight from Equal Weight at Barclays
- UHS Earnings: Universal Health Jumps after Huge EPS, Guidance Beats